Lord's Mark Industries Limited disclosed multiple acquisitions of equity shares by various acquirers pursuant to a resolution plan and scheme of amalgamation approved by the National Company Law Tribunal (NCLT), Mumbai Bench. The transactions, finalized on June 23, 2026, involve the allotment of shares to individuals including Hariram Vibhuti Upadhyay, Manav Kishore Teli, and Manish Hariram Upadhya. These allotments are exempt from the mandatory open offer requirements under Regulation 10(1)(da) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Background

The acquisitions follow the approval of a resolution plan under Section 31 of the Insolvency and Bankruptcy Code, 2016, and a scheme sanctioned by the NCLT vide its order dated July 28, 2025. Lord's Mark Industries Limited, formerly known as Lords Mark India Limited and Kratos Energy & Infrastructure Limited, submitted revised disclosures to BSE Limited on July 8, 2026, to comply with Regulation 10(6) of the SEBI (SAST) Regulations, 2011. The company clarified that the price of acquisition is not applicable as the shares were allotted pursuant to the approved resolution plan.

Transaction Details

The following table summarizes the key details of the share allotments made on June 23, 2026:

Shareholding Pattern

The disclosures detail the change in shareholding status for the acquirers. Prior to these transactions, the acquirers held no shares in the target company. The post-transaction shareholding reflects the percentages listed in the table above. The disclosures were signed by the respective acquirers in Mumbai on July 8, 2026.

Lords Mark Industries Limited has acquired a 30% equity stake in Aivita Private Limited for a cash consideration of ₹3,00,000, marking a strategic expansion into the robotic surgery sector. The acquisition, completed on July 3, 2026, involves the purchase of 30,000 equity shares of ₹10 each. This move positions Aivita as an associate company of Lords Mark Industries Limited, aligning with the acquirer's long-term vision to bolster India's healthcare infrastructure through advanced medical technologies and indigenous innovation.

Aivita Private Limited is a healthcare technology company incorporated on April 23, 2026, under the Companies Act, 2013. The entity focuses on building an execution and intelligence layer for robotic surgery in India. As a recently incorporated entity, Aivita holds an Authorised Share Capital of ₹25,00,000 and a Paid-up Share Capital of ₹10,00,000. Audited financial statements and turnover details are not yet available due to its recent establishment.

The transaction does not constitute a related party transaction, and no interests are held by the promoter or promoter group of Lords Mark Industries Limited in Aivita. The acquisition was executed for cash, and no specific governmental or regulatory approvals were required beyond standard statutory compliances. The investment is intended to confer significant influence over Aivita, facilitating the deployment of robotic surgical platforms and enhancing surgeon training programs.

Mr. Sachidanand Upadhyay, Managing Director of Lords Mark Industries Limited, emphasized that the investment is a commitment to the future of Indian healthcare. He stated that the strategic shareholding aims to make advanced robotic surgery more accessible, strengthen clinical capabilities, and foster an ecosystem where technology improves patient outcomes. The acquisition complements Lords Mark's existing healthcare portfolio, which includes diagnostics, medical devices, AI-enabled solutions, and indigenous manufacturing.

Key Details of the Acquisition

Strategic Objectives

The acquisition is designed to integrate Aivita's technological capabilities with Lords Mark's healthcare portfolio. The companies aim to create a hardware-agnostic robotic surgery ecosystem that connects technology, hospitals, clinicians, and healthcare data. This initiative seeks to improve the utilization of advanced medical infrastructure and promote technology-enabled collaboration across the country's healthcare sector.